VERTEX PHARMACEUTICA

VRTX
Delayed Quote. Delayed  - 06/28 04:00:01 pm
276.17USD -3.88%

Turn to zoom
Prev.276.1700
Open288.4500
High289.4100
Low275.9700
Volume1 926 506
Latest news
13h ago
06/15
06/13
06/13
Chart VERTEX PHARMACEUTICALS
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishBullish
Resistance293293293
Spread/Res.-5,6%-5,6%-5,6%
Spread/Supp.2,8%10%20%
Support269251230
Financials
Sales 2022 8 593 M - -
Net income 2022 3 246 M - -
Net cash 2022 10 813 M - -
P/E ratio 2022 21,9x
Yield 2022 -
Capitalization 70 632 M 70 632 M -
EV / Sales 2022 6,96x
EV / Sales 2023 6,04x
Nbr of Employees 3 900
Free-Float 99,7%
Company
Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases. Net sales break down by type of income as follows:
- income from sales of products (99.9%);
-...
Sector :
Bio Therapeutic Drugs
Calendar :
2022-07-27 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Last Close Price 276,17 $
Average target price 294,22 $
Spread / Average Target 6,53%